Downregulation of ARNT2 promotes tumor growth and predicts poor prognosis in human hepatocellular carcinoma

Publisher： John Wiley & Sons Inc

E-ISSN： 1440-1746|30|6|1085-1093

ISSN： 0815-9319

Source： JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, Vol.30, Iss.6, 2015-06, pp. : 1085-1093

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Numb downregulation suppresses cell growth and is associated with a poor prognosis of human hepatocellular carcinoma

By                                  

International Journal of Molecular Medicine, Vol. 36, Iss. 3, 2015-01 ,pp. : 653-660

Spandidos Publications

Access to resources Recommend Favorite

BARX2 in hepatocellular carcinoma

By  

HEPATOLOGY RESEARCH, Vol. 45, Iss. 2, 2015-01 ,pp. : 228-237

John Wiley & Sons Inc

Access to resources Recommend Favorite

RBMY, a novel inhibitor of glycogen synthase kinase 3β, increases tumor stemness and predicts poor prognosis of hepatocellular carcinoma

By  

HEPATOLOGY, Vol. 62, Iss. 5, 2015-11 ,pp. : 1480-1496

John Wiley & Sons Inc

Access to resources Recommend Favorite

Loss of CD155 expression predicts poor prognosis in hepatocellular carcinoma

By  

HISTOPATHOLOGY, Vol. 66, Iss. 5, 2015-04 ,pp. : 706-714

John Wiley & Sons Inc

Access to resources Recommend Favorite

ANGPTL2 promotes liver cancer metastasis

By  

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, Vol. 30, Iss. 2, 2015-02 ,pp. : 396-404

John Wiley & Sons Inc

Access to resources Recommend Favorite